Inside News
GAIT Trial Results
Current News
Past News

Home Page
News
Supplements
Resources
Products
Books
Q & A
About Dr. Theo


Recent Articles

31,000 faulty hip implants need replacing

Coffee drinking may be linked to Rheumatoid Arthritis

Chondroitin shown to benefit cartilage structure

Glucosamine also shown to benefit cartilage structure

Chondroitin and glucosamine together works better than either alone

Genetically engineered drug development on rhIGF-I halted because it did not work

Enzyme Blamed as Cause for Lupus

Search for genetic basis of osteoarthritis - Summary / (See also) Original Press Release

UCSF Finding Could Lead To New Class of Pain Relieving Drugs

New Inhaler Adapter for Elderly and Arthritic COPD Patients

Arthritis in America: A National Report Card. It isn't good!

FDA Panel Recommends Vioxx For Acute Pain, Osteoarthritis

New software helps surgeons plan for osteotomy surgery

Remicade Shows Positive Results In Rheumatoid Arthritis At One Year

FDA Approves Enbrel For Juvenile Rheumatoid Arthritis

Scleroderma Helped by Minocycline
Antibiotic Minocycline Reverses Disfiguring and Debilitating Skin Disease Scleroderma

Chondroitin, Kava Kava, 5HTP, Garlic, Selenium Now Among Ten Most PopularNutritional Supplements
Curious about what your neighbors keep in their kitchen cabinets?  Nutritional supplements of course. Chondroitin/Glucosamine, Kava Kava, 5HTP, Garlic and Selenium are now among the ten most popular supplements in the U.S., according to the most recent consumer tracking report conducted by NBTY Inc., a leader in the dietary supplement industry

New Study Results for LYMErix™ Demonstrate Individuals can be Immunized Faster
Three doses of LYMErix™ when given to adults on an accelerated dosing schedule of 0, 1, 2 months provide a comparable antibody response to that obtained in the LYMErix pivotal efficacy trial, according to a new study presented today at the 36th annual meeting of the Infectious Diseases Society of America (IDSA) in Denver.

FDA panel recommends blood-filter treatment for rheumatoid arthritis
An advisory panel to the U.S. Food and Drug Administration Thursday recommended approval of a blood filtering device to treat some cases of rheumatoid arthritis.

FDA Advisory Committee Recommends Enbrel For Rheumatoid Arthritis
The United States Food and Drug Administration’s arthritis advisory committee has recommended the approval of Immunex Corp.’s Enbrel(TM) (etanercept) for the treatment of active rheumatoid arthritis (RA).

ACG MEETING: Studies Show Vioxx Does Not Damage Gastrointestinal Tract
Merck & Co.’s Vioxx, an investigational medicine for pain and arthritis, showed no significant differences from placebo in effects on the mucosal integrity of the gastrointestinal (GI) tract, while the NSAIDs ibuprofen and indomethacin produced damage.

Osteoarthritis In Hands May Be Related To Grip Strength

FDA Grants Priority Review To Vioxx For Osteoarthritis And Pain

FDA Approves Celebrex For Osteoarthritis And Rheumatoid Arthritis

Juvenile Rheumatoid Arthritis Linked to Low Levels of Certain Hormones

Hyalgan Safe, Effective For Osteoarthritis of The Knee

FDA Committee Recommends Celebrex For Arthritis

ACR MEETING: Celebrex Relieves Arthritis Pain As Well As NSAIDs


 
 

Learn about and purchase the book

90% of people who follow The Arthritis Cure treatment program don't need anti-inflammatories (like Aleve, Celebrex or Advil).
Dr. Theo warned people that these drugs, used first... read more

 

  

Copyright ©1997-2005 Jason Theodosakis, M.D.
Privacy Policy
Please read this site's disclaimer.